San Francisco, CA – Genentech is a company we’ve covered quite a few times for their innovative experiences and general attitude toward healthcare. This is no different.

The innovative healthcare company from San Francisco is taking the lead is pushing for some progress in an area of cancer where 95 percent of cases could be prevented or effectively cured if caught early through regular, standard Pap tests and human papillomavirus (HPV) screening. The screenings are now even more accessible due to the Affordable Care Act which enabled young women to stay on their parents insurance plans through the age of 25. The recommended age to start getting screened for Cervical Cancer is 21, so why are we not catching more cases early enough to stop them?

Genentech is sponsoring the Quest Award and their goal is to generate some bold new healthcare solutions that will impact the this fight against cervical cancer. This competition is providing startups an opportunity apply until February 11th. Healthcare is continuing to be disrupted by these small innovative companies over the past few years and it is great to see that being embraced with the creation of things like the Quest Award.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.